Treatment outcomes of a Swiss non-infectious paediatric uveitis cohort: retrospective study over ten years
The step-up treatment approach shows a safe profile in regards to VA outcome. Methotrexate presents a high rate of treatment failure and adverse effects. Adalimumab and infliximab are effective and safe. Timely treatment escalation might lower treatment burden for affected children, their families, and health care providers.
Authors
- Fabio Meier
- Jeanne Martine Gunzinger (ORCID: https://orcid.org/0000-0001-9005-347X)
- Brigitte Simonsz‐Tóth (ORCID: https://orcid.org/0000-0003-2429-3787)
- Christina Gerth‐Kahlert (ORCID: https://orcid.org/0000-0001-6298-615X)
- Alice Miriam Kitay
- Seraina Palmer Sarott
- Christian Böni
Institutions
- University of Zurich (CH)
- University Hospital of Zurich (CH)
- University Children's Hospital Zurich (CH)
Publication Details
- Journal
- Journal of Ophthalmic Inflammation and Infection
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1186/s12348-025-00458-w
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00